Huntsman Corporation 2024 Annual Report (10-K) Summary
Business Context and Reporting Period
This summary covers the fiscal year ended December 31, 2024, for Huntsman Corporation and its wholly-owned subsidiary, Huntsman International LLC. Huntsman is a global manufacturer of diversified organic chemical products operating in three segments: Polyurethanes (MDI, polyols, TPU), Performance Products (amines, maleic anhydride), and Advanced Materials (epoxy, phenoxy, acrylic formulations). The company serves industrial and building product manufacturers globally, with a strategic focus on energy efficiency and lightweighting applications.
Key Financial Metrics (2024)
| Metric | 2024 Value | 2023 Value |
|---|---|---|
| Revenues | $6,036 million | $6,111 million |
| Net (Loss) Income | $(127) million | $153 million |
| Net (Loss) Income Attributable to Huntsman Corp | $(189) million | $101 million |
| Adjusted EBITDA | $414 million | $472 million |
| Free Cash Flow (Continuing Ops) | $101 million | $21 million |
| Operating Cash Flow (Continuing Ops) | $285 million | $251 million |
| Capital Expenditures | $(184) million | $(230) million |
| Total Debt | $1,835 million | $1,688 million |
| Cash and Cash Equivalents | $340 million | $540 million |
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased 1% year-over-year, driven by lower average selling prices across all segments, partially offset by higher sales volumes.
- Net Loss: The company reported a net loss of $127 million in 2024 compared to net income of $153 million in 2023. This shift was primarily due to:
- One-Time Charges: A $71 million prepaid asset write-off and a $39 million loss on the dissolution of subsidiaries related to the separation of the SLIC joint venture in China.
- Restructuring Costs: Increased restructuring, impairment, and plant closing costs of $39 million (up 117% from 2023).
- Lower Equity Income: Equity income from unconsolidated affiliates dropped to $44 million from $83 million, largely due to lower earnings at the PO/MTBE joint venture in China.
- Segment Performance:
- Polyurethanes: Revenues increased 1% due to volume gains, though Adjusted EBITDA dipped slightly.
- Performance Products: Revenues fell 6% and Adjusted EBITDA dropped 24% due to competitive pricing pressures.
- Advanced Materials: Revenues declined 3% with a 4% drop in Adjusted EBITDA due to unfavorable sales mix.
- Debt Structure: Total debt increased to $1.835 billion, including the issuance of $350 million in 5.70% Senior Notes due 2034. Current portion of debt rose significantly to $325 million due to the reclassification of the €300 million 2025 Senior Notes.
Guidance, Outlook, and Risks
- Liquidity: As of December 31, 2024, the company held $340 million in cash with $1.197 billion available under its revolving credit facility and $182 million under accounts receivable programs. Total liquidity stood at approximately $1.72 billion.
- Capital Expenditures: Management expects to spend between $180 million and $190 million on capital expenditures in 2025, funded by operating cash flow.
- Debt Maturities: The €300 million (approx. $320 million) 2025 Senior Notes mature on April 1, 2025. The company intends to renew, repay, or extend this facility.
- Legal Contingency: On February 6, 2025, the Louisiana Supreme Court affirmed a judgment in Huntsman's favor against Praxair/Linde. The company expects to receive net proceeds of approximately $25 million to $30 million, though the timing is uncertain.
- Risks: Key risks include volatile raw material and energy costs, global economic downturns affecting demand, currency exchange fluctuations, and regulatory changes regarding greenhouse gas emissions (e.g., EU ETS, California climate laws).
Key Facts for Investor Verification
- SLIC Joint Venture Separation: Verify the final accounting treatment of the $71 million prepaid asset write-off and the $51 million bargain purchase gain related to the acquisition of assets from the Shanghai Liengheng Isocyanate Company Ltd. (SLIC) joint venture.
- Valuation Allowances: Review the $255 million total valuation allowance on deferred tax assets, which increased by $34 million in 2024 due to cumulative losses in specific jurisdictions (Germany, Luxembourg, U.K., Netherlands).
- 2025 Debt Maturity: Confirm the company's specific plan for refinancing or repaying the €300 million Senior Notes maturing in April 2025.
- Restructuring Progress: Monitor the execution of ongoing restructuring programs in Europe and the Polyurethanes segment, with expected remaining cash costs of approximately $25 million through 2026.
- Praxair/Linde Litigation: Track the actual receipt of the ~$25-30 million net proceeds from the affirmed court judgment against Praxair/Linde.